• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国稀有捐赠者计划:25 年支持稀有血液需求。

The American Rare Donor Program: 25 years supporting rare blood needs.

机构信息

1American Rare Donor Program, Biomedical Services, American Red Cross, Philadelphia, PA.

出版信息

Immunohematology. 2024 Oct 4;40(3):100-121. doi: 10.2478/immunohematology-2024-015. Print 2024 Sep 1.

DOI:10.2478/immunohematology-2024-015
PMID:39373302
Abstract

Rare donor programs are critically important for those patients with rare phenotypes who have produced the associated alloantibodies that necessitate the provision of rare blood components. We describe the American Rare Donor Program (ARDP) and its establishment, members, and policies. The specific phenotypes meeting the ARDP criteria for inclusion are described. Data on the number of rare donors registered by year, and the number of requests for rare blood components received and fulfilled over the 25 years of the program (1998-2023) are provided, along with a description of some notable cases and discussion of how the program supports patients with sickle cell disease.

摘要

稀有供者计划对于那些产生相关同种异体抗体的稀有表型患者非常重要,这些抗体需要提供稀有血液成分。我们描述了美国稀有供者计划(ARDP)及其建立、成员和政策。描述了符合 ARDP 纳入标准的特定表型。提供了按年份注册的稀有供者数量的数据,以及该计划 25 年来收到和满足的稀有血液成分请求数量,并描述了一些值得注意的病例,并讨论了该计划如何为镰状细胞病患者提供支持。

相似文献

1
The American Rare Donor Program: 25 years supporting rare blood needs.美国稀有捐赠者计划:25 年支持稀有血液需求。
Immunohematology. 2024 Oct 4;40(3):100-121. doi: 10.2478/immunohematology-2024-015. Print 2024 Sep 1.
2
In search of red blood cells for alloimmunized patients with sickle cell disease.为患有镰状细胞病的同种免疫患者寻找红细胞。
Immunohematology. 2006;22(3):136-42.
3
Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.美国稀有供体计划中供体的GYPB和RH分子特征分析。
Immunohematology. 2006;22(3):143-7.
4
The American Rare Donor Program.美国稀有供者计划。
J Crit Care. 2013 Feb;28(1):110.e9-110.e18. doi: 10.1016/j.jcrc.2012.02.017. Epub 2012 Apr 18.
5
The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.在学术中心,为地中海贫血症和镰状细胞贫血症患者输注表型血液单位的价值。
Transfusion. 2020 Feb;60 Suppl 1:S15-S21. doi: 10.1111/trf.15682.
6
Transfusion protocol for patients with sickle hemoglobinopathies at Children's National Medical Center.儿童国家医疗中心镰状血红蛋白病患者的输血方案。
Immunohematology. 2012;28(1):13-6.
7
Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.使用分子分型的少数族裔红细胞供者来支持镰状细胞病长期输血成年患者的障碍。
Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9.
8
The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.镰状细胞病中同种免疫的预防与管理:红细胞扩展表型匹配的益处
Immunohematology. 2012;28(1):20-3.
9
Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories.非allo免疫性镰状细胞病患者供体红细胞单位的表型匹配:对1182家北美实验室的调查
Arch Pathol Lab Med. 2005 Feb;129(2):190-3. doi: 10.5858/2005-129-190-PMODRB.
10
Relevance of blood groups in transfusion of sickle cell disease patients.血型在镰状细胞病患者输血中的相关性。
C R Biol. 2013 Mar;336(3):152-8. doi: 10.1016/j.crvi.2012.09.011. Epub 2013 Feb 7.

引用本文的文献

1
Blood Borders: State laws, vaccine misinformation, and the threat to the United States blood supply.《血液边界:州法律、疫苗错误信息以及对美国血液供应的威胁》
Transfusion. 2025 Aug;65(8):1534-1542. doi: 10.1111/trf.18312. Epub 2025 Jun 16.